ID   UROtsa Cd#1-SPARC
AC   CVCL_LM65
SY   Cd#1-SPARC
DR   Wikidata; Q54991828
RX   PubMed=26783756;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11219; SPARC.
CC   Transformant: ChEBI; CHEBI_48775; Cadmium(2+).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IX03 ! UROtsa Cd#1
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 9
//
RX   PubMed=26783756; DOI=10.1371/journal.pone.0147362; PMCID=PMC4718619;
RA   Slusser-Nore A., Larson-Casey J.L., Zhang R.-W., Zhou X.-D., Somji S.,
RA   Garrett S.H., Sens D.A., Dunlevy J.R.;
RT   "SPARC expression is selectively suppressed in tumor initiating
RT   urospheres isolated from As+3- and Cd+2-transformed human urothelial
RT   cells (UROtsa) stably transfected with SPARC.";
RL   PLoS ONE 11:e0147362.1-e0147362.22(2016).
//